Pancreatic Cancer Research

ResearcherCharles UniversityNo recent work listed

Lukáš Havlůj

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9896-5534; OpenAlex author ID A5058687948. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Segmental Versus Partial Portomesenteric Resection in Pancreatectomy for Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2023.03.002↗
  2. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience. Last author DOI 10.3389/pore.2021.1609756↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adam Whitley · 2 shared papers, 2021–2023 · strength 0.37
  2. David Girsa · 1 shared paper, 2023 · strength 0.22
  3. R Gürlich · 1 shared paper, 2023 · strength 0.22
  4. Kateřina Lawrie · 1 shared paper, 2023 · strength 0.22
  5. Peter Baláž · 1 shared paper, 2023 · strength 0.22
  6. Jan Hrudka · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.